[vc_row full_width=”stretch_row_content_no_spaces”][vc_column][rev_slider slidertitle=”Architecture” alias=”architecture”][/vc_column][/vc_row][vc_row full_width=”stretch_row_content” equal_height=”yes” css=”.vc_custom_1654083971377{border-top-width: 3px !important;padding-top: 50px !important;padding-bottom: 50px !important;border-top-color: #fdd378 !important;border-top-style: solid !important;}”][vc_column width=”5/12″ offset=”vc_col-lg-offset-1 vc_col-md-offset-0 vc_col-md-5 vc_col-sm-offset-0″][vc_column_text]

Neoantigens.unique

[/vc_column_text][/vc_column][vc_column width=”1/2″ css=”.vc_custom_1638191500737{padding-right: 25px !important;}” offset=”vc_col-lg-offset-1 vc_col-lg-5 vc_col-md-offset-0 vc_col-md-6 vc_col-sm-offset-0″][vc_column_text]

What if we could visualise how mutations change the surface of cancer cells? Explore what makes them distinct? It would enable us to identify the best possible targets and design medicines that specifically recognise and kill cancer cells.

[/vc_column_text][vc_column_text]

At Imuno we broaden the repertoire of cancer-specific epitopes to lay the foundation for novel targeted therapies. It is our ambition to build a best-in-class artificial intelligence platform to accurately identify cancer-escape epitopes, and to grow our off-the-shelf portfolio of targeted therapies.

[/vc_column_text][/vc_column][/vc_row][vc_row full_width=”stretch_row_content” equal_height=”yes” el_id=”learn-more”][vc_column width=”1/12″ css=”.vc_custom_1637164668680{background-color: #fdd378 !important;}”][/vc_column][vc_column width=”4/12″ css=”.vc_custom_1637864498906{padding-top: 100px !important;padding-right: 30px !important;padding-bottom: 80px !important;background-color: #fdd378 !important;}”][vc_column_text]

Accurate cross-reactivity prediction

[/vc_column_text][vc_column_text]

Imuno is pioneering the power of machine learning to build a structure-based discovery engine to identify cancer-specific epitopes that can be exploited by novel therapeutic strategies. Our discovery engine identifies potential cross-reactive epitopes, providing a cohesive link with conventional in-vitro safety studies. It delivers missing information and better guidance to develop safe therapies.

[/vc_column_text][lab_button title=”Partnership opportunities” type=”outlined-bg” button_bg=”custom” button_txt_custom=”#000000″ button_txt_hover_custom=”#ffffff” css=”.vc_custom_1653486399697{border-top-width: 1px !important;border-right-width: 1px !important;border-bottom-width: 1px !important;border-left-width: 1px !important;padding-top: 16px !important;padding-right: 24px !important;padding-bottom: 16px !important;padding-left: 24px !important;border-left-color: #000000 !important;border-left-style: solid !important;border-right-color: #000000 !important;border-right-style: solid !important;border-top-color: #000000 !important;border-top-style: solid !important;border-bottom-color: #000000 !important;border-bottom-style: solid !important;}” button_bg_custom=”#000000″ el_class=”cursor: pointer;” link=”url:https%3A%2F%2Fwww.imunotx.com%2Fcontact%2F|target:_blank”][/vc_column][vc_column width=”1/12″ css=”.vc_custom_1637164731106{background-color: #fdd378 !important;}”][/vc_column][vc_column width=”6/12″ offset=”vc_col-lg-offset-0 vc_col-sm-offset-0 vc_hidden-xs” css=”.vc_custom_1637864745583{background-image: url(http://www.imunotx.com/wp-content/uploads/2021/11/national-cancer-institute-cI8T6zeDbZw-unsplash-1-scaled.jpg?id=5274) !important;background-position: center !important;background-repeat: no-repeat !important;background-size: cover !important;}”][/vc_column][/vc_row][vc_row css=”.vc_custom_1653481942147{padding-top: 50px !important;padding-bottom: 50px !important;}” el_id=”platform”][vc_column css=”.vc_custom_1638795519815{margin-top: 10px !important;background-position: center !important;background-repeat: no-repeat !important;background-size: contain !important;}”][vc_column_text css=”.vc_custom_1638796120230{padding-bottom: 50px !important;}”]

Our technology.platform 

[/vc_column_text][vc_single_image image=”5310″ img_size=”full” alignment=”center”][/vc_column][/vc_row][vc_row full_width=”stretch_row_content” equal_height=”yes” css=”.vc_custom_1638191683898{padding-top: 75px !important;padding-bottom: 75px !important;background-color: #fdd378 !important;}”][vc_column width=”1/3″ offset=”vc_hidden-lg vc_hidden-md vc_hidden-sm”][vc_column_text]

Team.unique 

[/vc_column_text][/vc_column][vc_column width=”1/2″ css=”.vc_custom_1638191631778{padding-right: 25px !important;}” offset=”vc_col-lg-offset-1 vc_col-lg-5″][vc_column_text]

Founded by a pioneering scientist who embraced himself with leading experts in the biopharmaceutical industry. Imuno has the right skillset, and a team with decades of experience developing groundbreaking life-sciences companies. As such, Imuno is ready to build a successful biopharmaceutical company developing next-generation targeted therapies. 

[/vc_column_text][lab_button title=”Our team (soon)” type=”outlined-bg” button_bg=”custom” button_txt_custom=”#000000″ button_txt_hover_custom=”#ffffff” css=”.vc_custom_1654083792607{border-top-width: 1px !important;border-right-width: 1px !important;border-bottom-width: 1px !important;border-left-width: 1px !important;padding-top: 16px !important;padding-right: 24px !important;padding-bottom: 16px !important;padding-left: 24px !important;border-left-color: #000000 !important;border-left-style: solid !important;border-right-color: #000000 !important;border-right-style: solid !important;border-top-color: #000000 !important;border-top-style: solid !important;border-bottom-color: #000000 !important;border-bottom-style: solid !important;}” button_bg_custom=”#000000″ el_class=”cursor: pointer;”][/vc_column][vc_column width=”1/2″ offset=”vc_col-lg-offset-1 vc_col-lg-5 vc_hidden-xs”][vc_column_text]

Team.unique 

[/vc_column_text][/vc_column][/vc_row][vc_row css=”.vc_custom_1638796174243{padding-top: 50px !important;padding-bottom: 50px !important;}”][vc_column css=”.vc_custom_1638795519815{margin-top: 10px !important;background-position: center !important;background-repeat: no-repeat !important;background-size: contain !important;}”][vc_column_text css=”.vc_custom_1638798550319{padding-bottom: 50px !important;}”]

Update.news 

[/vc_column_text][lab_blog_posts masonry=”masonry” blog_posts_options=”date” hover_layer_icon=”static” blog_query=”size:6|order_by:date|post_type:post” image_size=”large”][/vc_column][/vc_row]